PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Bespak launches next-generation nasal drug product development offering through new collaboration with Upperton

Strategic collaboration addresses market need for integrated nasal drug-device product development and commercialisation, combining formulation, analytical, device e...
Continue Reading →
News

Yourgene Health Insight DPYD Assay Achieves IVDR Accreditation

Comprehensive pharmacogenetic testing solution aligned with latest clinical guidance to support informed chemotherapy treatment decisions Yourgene Health (part of...
Continue Reading →
News

New Pharmaceutical Sustainability Guide Tackles Growing Industry Pressures

Tunley Environmental has launched a new science-based guide to help pharmaceutical and medical device companies respond to growing sustainability, procurement and pr...
Continue Reading →
News

Shilpa Biologicals and SPIMACO Bio Sign Strategic license agreement for PD-1 Biosimilar for MENA Market

Shilpa Biologicals to serve as exclusive development, technology transfer and manufacturing partner with SPIMACO Bio leading regulatory approval commercialisati...
Continue Reading →
News

Oncodesign Services and Nexus BioQuest partner to give biotechs a clearer route to specialist preclinical expertise

Oncodesign Services and Nexus BioQuest have formed a partnership connecting their respective in vitro and in vivo expertise, giving biotech companies a clearer route...
Continue Reading →
News

Parker to Showcase Engineered Biopharma Processing Solutions at CPHI 2026

Solutions for cleaner, more reliable pharmaceutical processes  6 to 8 October 2026 | Hall 12, Booth 12M45 | Milan, Italy Parker Hannifin, the global leade...
Continue Reading →
News

Sygnature Discovery establishes DEL screening collaboration with X-Chem 

Sygnature Discovery, a leading integrated drug discovery contract research organisation (CRO), has established a formal collaboration with X-Chem, a data-driven drug...
Continue Reading →
News

Scenic Biotech Appoints Renowned Neurology Drug Development Leader Dr. Judith Walker as Chief Medical Officer

Dr. Walker joins to lead Scenic's transition into clinical development and shape its clinical strategy Lead program SC6177 is advancing toward the clinic with a f...
Continue Reading →
News

Teitur Trophics announces successful results from Phase I clinical trial of first-in-class Parkinson’s disease peptide TT-P34

Study shows TT-P34 is safe and well tolerated in healthy volunteers and patients with early-stage Parkinson's disease (PD), with pharmacokinetics confirming robust ...
Continue Reading →
News

Samsung Biologics signs USD 262 million manufacturing agreement with European pharmaceutical company

Agreement The agreement was disclosed in accordance with Korean market disclosure requirements. The new USD 262 million manufacturing agreement with a Eur...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026